Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines
- PMID: 22295871
- PMCID: PMC3330824
- DOI: 10.1021/np200414c
Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines
Abstract
Berkeley Pit Lake, Butte, Montana, is a 540 m deep abandoned open-pit copper mine filled with over 140 billion liters of acidic, metal-sulfate-contaminated water. This harsh environment has yielded several microorganisms that produce interesting biologically active compounds. Several polyketide metabolites including the new berkazaphilones A (1) and B (2) and octadienoic acid derivatives berkedienoic acid (13) and berkedienolactone (15), as well as previously reported azaphilone 4, vermistatin (6), dihydrovermistatin (7), penisimplicissin (8), aldehyde 9, and methylparaconic acid (11), were isolated from a culture broth of Penicillium rubrum taken from a depth of 270 m. The structures of these compounds were deduced by interpretation of spectroscopic data. The compounds were isolated either for their inhibition of the signal transduction enzyme caspase-1 or because of their structural similarity to these inhibitors. Selected compounds were further evaluated for their ability to inhibit interleukin-1β production by inflammasomes in induced THP-1 cells. Berkazaphilones B (2) and C (4) and vermistatin analogue penisimplicissin (8) exhibited selective activity against leukemia cancer cell lines in the National Cancer Institute 60 human cell line assay.
References
-
- Montana Bureau of Mines and Geology [accessed 5/16/11];Berkeley Pit and Butte Mine-Flooding Operable Unit. website: http://www.mbmg.mtech.edu/env-berkeley.htm.
-
- Stierle A, Stierle D. Bioprospecting in the Berkeley Pit: Bioactive Metabolites from Acid Mine Waste Extremophiles. In: Atta-Ur-Rahman, editor. Bioactive Natural Products. Volume 32. Elsevier Science Publishers; Amsterdam: 2005.
-
- Stierle AA, Stierle DB, Parker K, Goldstein E, Bugni T, Baarson C, Gress J, Blake D. J. Nat. Prod. 2003;66:1097–1100. - PubMed
-
- Stierle D, Stierle A, Hobbs JD, Stokken J, Clardy J. Org. Lett. 2004;6:1049–1052. - PubMed
-
- Stierle A, Stierle D, Kemp K. J. Nat. Prod. 2004;67:1392–1395. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA139159/CA/NCI NIH HHS/United States
- P20 GM103546/GM/NIGMS NIH HHS/United States
- P20RR017670/RR/NCRR NIH HHS/United States
- 5P30NS055022/NS/NINDS NIH HHS/United States
- RC2ES018742/ES/NIEHS NIH HHS/United States
- R01CA139159/CA/NCI NIH HHS/United States
- P20RR16455-04/RR/NCRR NIH HHS/United States
- P30 GM103338/GM/NIGMS NIH HHS/United States
- P30 NS055022/NS/NINDS NIH HHS/United States
- RC2 ES018742/ES/NIEHS NIH HHS/United States
- P20 RR016455/RR/NCRR NIH HHS/United States
- P20 RR017670/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources